A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder
To access this article, please choose from the options below
Study received institutional review board approval.
Clinical Trial Registration NCT00290563 (www.clinicaltrials.gov).
Supported by Merck & Co., Inc.
For other articles on a related topic see pages 762, 769 and 783.
PII: S0022-5347(10)03275-1
doi:10.1016/j.juro.2010.03.147
© 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc All rights reserved.

